Trial intelligence / Profile preview

Lidocaine prilocaine spray for primary premature ejaculation

CTR20241900Phase 3Completed

Sponsor
Jiangsu Kefeiping Pharmaceutical Co., Ltd.
Start
May 2024
Modality
Small Molecules, Drug Delivery Systems
Countries
1
01

Overview

A Phase 3 trial of lidocaine + prilocaine in premature ejaculation (PE), sponsored by Jiangsu Kefeiping Pharmaceutical Co., Ltd.. Started May 2024; status: completed.

02

Drugs

lidocaine + prilocaine
03

Conditions

premature ejaculation (PE)

Beyond the preview

Go deeper on CTR20241900.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20241900.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call